NEW ORLEANS — For people with type 2 diabetes (T2D) inadequately controlled on submaximal dulaglutide (Trulicity) doses, switching to tirzepatide (Mounjaro) produces significantly greater A1c and weight lowering than does escalating dulaglutide treatment. “Often, when we are with a patient who is not meeting treatment goals...
The Center For Mind & Esteem Development, Inc.
A Course In Personal & Professional Development
LoveNow360 for Self, Community & World
Engagement & Empowerment
Marvin Mack, Founder & Creative Direcotr
The Center For Mind & Esteem Development, Inc. A Course In Personal & Professional LoveNow360 for Self, Community & World Engagement & Empowerment Marvin Mack, Founder & Creative Director lovenow360.net
4109716235
personaldevelopment@me.com
Copyright © 2023 lovenow360worldnews. All Rights Reserved
